Beats / 81 priced constituents
robotics
An equal-weight index of the priced names on this beat, rebuilt every Friday from the constituents that were actually in it.
183.1-2.4%base 100 · to 2026-10-02
This week
Up most
- Accuray+27.7%
- Cognex+10.8%
- Celestica+6.0%
- Jenoptik+5.9%
- Rockwell Automation+4.7%
Down most
- Vicarious Surgical-45.0%
- Nauticus Robotics-34.5%
- Kodiak AI-32.5%
- Eve Holding-19.8%
- Archer Aviation-12.8%
What happened
| Date | Type | What happened | Source |
|---|---|---|---|
| 2026-10-05 | editorial note | Sources added: 0 → 1The dossier's cited-link count grew from 0 to 1 (deep-dive-2026-06-24.md → deep-dive-2026-10-05.md). | dossier |
| 2026-10-05 | editorial note | Margin figure revised: 66.3% → 68.2%Margin moved from 66.3% (deep-dive-2026-06-24.md) to 68.2% (deep-dive-2026-10-05.md). | dossier |
| 2026-10-05 | editorial note | Revenue figure revised: $1,781M → $97.93BRevenue moved from $1,781M (deep-dive-2026-06-24.md) to $97.93B (deep-dive-2026-10-05.md). | dossier |
| 2026-10-05 | editorial note | Verdict changed: A reserve-distorted GAAP optic hides a clean ~6-7% operational compounder that has visibly grown THROUGH the STELARA cliff; at ~20.6x forward adj EPS it is a quality-at-fair-price ho…Before (deep-dive-2026-06-24.md): A reserve-distorted GAAP optic hides a clean ~6-7% operational compounder that has visibly grown THROUGH the STELARA cliff; at ~20.6x forward adj EPS it is a quality-at-fair-price hold whose re-rate gate is talc tail-risk resolution and Orthopaedics/Ottava optionality, not the P&L. After (deep-dive-2026-10-05.md): The two re-rate gates the June dossier named have both swung open — a proposed $5.5B ovarian-talc resolution and FDA De Novo for OTTAVA — and the stock has priced most of them: a record $281.07 close on 2 Sep, now $256.03 (2 Oct close), ~23.2x the cut FY26 adj EPS guide and ~21.9x the $11.68 ex-deal figure after a ~9% pullback. JNJ is now a fair-to-full compounder, not a cheap one, whose next tests are MedTech deceleration and a ~$1.36 FY27 deal-dilution hit, not litigation. | dossier |
Dated ahead
| Date | Company | Period | Firmness |
|---|---|---|---|
| 2026-10-15 | Johnson & Johnson JNJ | 2026-Q3 | expected |
| 2026-10-21 | Intuitive Surgical ISRG | 2026-Q3 | expected |
| 2026-10-22 | Teledyne Technologies TDY | 2026-Q3 | expected |
| 2026-10-23 | Tesla TSLA | 2026-Q3 | expected |
| 2026-10-26 | Honeywell HON | 2026-Q3 | expected |
| 2026-10-27 | Celestica CLS | 2026-Q3 | expected |
| 2026-10-30 | Stryker SYK | 2026-Q3 | expected |
| 2026-11-02 | Aurora Innovation AUR | 2026-Q3 | expected |
| 2026-11-02 | FARO Technologies FARO | 2026-Q3 | expected |
| 2026-11-02 | Proto Labs PRLB | 2026-Q3 | expected |
| 2026-11-03 | JBT Marel JBTM | 2026-Q3 | expected |
| 2026-11-04 | PROCEPT BioRobotics PRCT | 2026-Q3 | expected |
| 2026-11-04 | Zebra Technologies ZBRA | 2026-Q4 | expected |
| 2026-11-05 | Accuray ARAY | 2026-Q3 | expected |
| 2026-11-05 | Cognex CGNX | 2026-Q4 | expected |
| 2026-11-05 | iRobot IRBT | 2026-Q3 | expected |
| 2026-11-05 | Regal Rexnord RRX | 2026-Q3 | expected |
| 2026-11-05 | Symbotic SYM | 2026-Q3 | expected |
| 2026-11-05 | Zimmer Biomet ZBH | 2026-Q3 | expected |
| 2026-11-06 | Aeva Technologies AEVA | 2026-Q3 | expected |